Qiaoming Zhi Selected Research

Nigericin

5/2021	Evidence of nigericin as a potential therapeutic candidate for cancers: A review.
1/2020	Molecular Screening for Nigericin Treatment in Pancreatic Cancer by High-Throughput RNA Sequencing.
9/2019	High-throughput sequencing of circRNAs reveals novel insights into mechanisms of nigericin in pancreatic cancer.
1/2018	Nigericin Exerts Anticancer Effects on Human Colorectal Cancer Cells by Inhibiting Wnt/β-catenin Signaling Pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qiaoming Zhi Research Topics

Disease

36	Neoplasms (Cancer) 05/2021 - 01/2013
16	Colorectal Neoplasms (Colorectal Cancer) 12/2022 - 03/2013
14	Pancreatic Neoplasms (Pancreatic Cancer) 02/2021 - 01/2014
11	Neoplasm Metastasis (Metastasis) 12/2022 - 01/2013
7	Stomach Neoplasms (Stomach Cancer) 01/2019 - 01/2013
6	Carcinogenesis 12/2022 - 01/2013
4	Breast Neoplasms (Breast Cancer) 01/2017 - 07/2014
4	Hepatocellular Carcinoma (Hepatoma) 01/2016 - 06/2013
3	Lymphatic Metastasis 01/2019 - 01/2016
2	Inflammation (Inflammations) 01/2019 - 01/2016
2	Adenocarcinoma 02/2017 - 12/2016
1	Colitis 01/2022
1	Colitis-Associated Neoplasms 01/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2017
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Hypoxia (Hypoxemia) 01/2017
1	Necrosis 01/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017
1	Urinary Bladder Neoplasms (Bladder Cancer) 10/2016
1	Chronic Pancreatitis 01/2016
1	Liver Neoplasms (Liver Cancer) 01/2016
1	Multiple Sclerosis 04/2015
1	Triple Negative Breast Neoplasms 04/2015
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2014
1	Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis) 04/2014
1	Edema (Dropsy) 01/2011
1	Fibrosis (Cirrhosis) 01/2011
1	Lung Injury 01/2011

Drug/Important Bio-Agent (IBA)

18	Biomarkers (Surrogate Marker)IBA 01/2019 - 03/2013
9	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2013
8	Biological ProductsIBA 01/2019 - 01/2013
7	CateninsIBA 09/2019 - 07/2015
7	MicroRNAs (MicroRNA)IBA 10/2016 - 01/2013
6	Long Noncoding RNAIBA 12/2022 - 01/2016
6	Indicators and Reagents (Reagents)IBA 12/2022 - 03/2013
5	Circular RNAIBA 01/2022 - 01/2019
5	Messenger RNA (mRNA)IBA 02/2021 - 07/2014
5	Cantharidin (Cantharides)IBA 02/2021 - 07/2015
4	NigericinIBA 05/2021 - 01/2018
3	RNA (Ribonucleic Acid)IBA 01/2022 - 05/2016
3	Epidermal Growth Factor (EGF)IBA 01/2017 - 04/2015
2	Conditioned Culture MediaIBA 01/2019 - 01/2016
2	LuciferasesIBA 01/2018 - 02/2015
2	Cisplatin (Platino)FDA LinkGeneric 01/2017 - 10/2013
2	ErbB Receptors (EGF Receptor)IBA 10/2016 - 10/2015
2	FH535IBA 07/2016 - 11/2015
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 07/2015 - 02/2014
2	Pharmaceutical PreparationsIBA 04/2015 - 10/2013
1	NF-kappa B (NF-kB)IBA 01/2022
1	IonophoresIBA 05/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	podocalyxinIBA 01/2019
1	Competitive Endogenous RNAIBA 01/2019
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019
1	ginsenoside Rg3IBA 01/2018
1	Untranslated RNA (Noncoding RNA)IBA 05/2017
1	SolutionsIBA 02/2017
1	Keratins (Keratin)IBA 02/2017
1	Fluorouracil (Carac)FDA LinkGeneric 01/2017
1	Docetaxel (Taxotere)FDA Link 01/2017
1	human ERBB2 proteinIBA 10/2016
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2016
1	Tyrosine Kinase InhibitorsIBA 10/2016
1	Lapatinib (GW572016)FDA Link 10/2016
1	Trastuzumab (Herceptin)FDA Link 10/2016
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2016
1	Odorant Receptors (Odorant Receptor)IBA 05/2016
1	elemeneIBA 01/2016
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2016
1	DisintegrinsIBA 01/2016
1	PhytochemicalsIBA 01/2016
1	CyclinsIBA 01/2016
1	dibutyldichlorotinIBA 01/2016
1	Metalloproteases (Metalloproteinases)IBA 01/2016
1	LipopolysaccharidesIBA 01/2016
1	Tumor Biomarkers (Tumor Markers)IBA 01/2016
1	norcantharidinIBA 11/2015
1	Gemcitabine FDA Link 11/2015
1	Epithelial Cell Adhesion MoleculeIBA 11/2015
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 11/2015
1	Polycomb-Group ProteinsIBA 10/2015
1	Progesterone Receptors (Progesterone Receptor)IBA 10/2015
1	Estrogen ReceptorsIBA 10/2015
1	Enhancer of Zeste Homolog 2 ProteinIBA 10/2015
1	Okadaic AcidIBA 07/2015
1	teriflunomideIBA 04/2015
1	Estrogens (Estrogen)FDA Link 04/2015
1	Progesterone FDA LinkGeneric 04/2015
1	DNA (Deoxyribonucleic Acid)IBA 04/2015
1	CarcinogensIBA 02/2015
1	Small Interfering RNA (siRNA)IBA 04/2014
1	salinomycinIBA 10/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2013

Therapy/Procedure

12	Therapeutics 01/2019 - 10/2013
5	Drug Therapy (Chemotherapy) 01/2018 - 10/2013
1	Photochemotherapy (Photodynamic Therapy) 05/2021
1	Radiotherapy 01/2017
1	Molecular Targeted Therapy 10/2016
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2016